May 2024
1. RUS T, Cuderman A, Georgiev D
   Parkinsonism Associated With Traumatic Hemorrhage in Substantia Nigra: Role of Presynaptic Dopaminergic Imaging.
   Neurology. 2024;102:e209384.
   

   >> Share

   
   
2. COURTNEY MR, Antonic-Baker A, Chen Z, Sinclair B, et al
   Association of Localizing (18)F-FDG-PET Hypometabolism and Outcome Following Epilepsy Surgery: Systematic Review and Meta-Analysis.
   Neurology. 2024;102:e209304.
   

   >> Share

   
   
3. BARATEAU L, Krache A, Da Costa A, Lecendreux M, et al
   Microglia Density and Its Association With Disease Duration, Severity, and Orexin Levels in Patients With Narcolepsy Type 1.
   Neurology. 2024;102:e209326.
   

   >> Share

   
   April 2024
4. WEINSTEIN G, Kojis DJ, Ghosh S, Beiser AS, et al
   Association of Neurotrophic Factors at Midlife With In Vivo Measures of beta-Amyloid and Tau Burden 15 Years Later in Dementia-Free Adults.
   Neurology. 2024;102:e209198.
   

   >> Share

   
   
5. CAI Y, Shi D, Lan G, Chen L, et al
   Association of beta-Amyloid, Microglial Activation, Cortical Thickness, and Metabolism in Older Adults Without Dementia.
   Neurology. 2024;102:e209205.
   

   >> Share

   
   March 2024
6. HONIG M, Altomare D, Caprioglio C, Collij L, et al
   Association Between Years of Education and Amyloid Burden in Patients With Subjective Cognitive Decline, MCI, and Alzheimer Disease.
   Neurology. 2024;102:e208053.
   

   >> Share

   
   
7. ACKLEY S, Calmasini C, Bouteloup V, Hill-Jarrett TG, et al
   Contribution of Global Amyloid-PET Imaging for Predicting Future Cognition in the MEMENTO Cohort.
   Neurology. 2024;102:e208054.
   

   >> Share

   
   February 2024
8. RAHAYEL S, Postuma R, Baril AA, Misic B, et al
   (99m)Tc-HMPAO SPECT Perfusion Signatures Associated With Clinical Progression in Patients With Isolated REM Sleep Behavior Disorder.
   Neurology. 2024;102:e208015.
   

   >> Share

   
   January 2024
9. PALLEIS C, Franzmeier N, Weidinger E, Bernhardt AM, et al
   Association of Neurofilament Light Chain, [(18)F]PI-2620 Tau-PET, TSPO-PET, and Clinical Progression in Patients With beta-Amyloid-Negative CBS.
   Neurology. 2024;102:e207901.
   

   >> Share

   
   December 2023
10. HANSEEUW BJ, Jacobs HIL, Schultz AP, Buckley RF, et al
    Association of Pathologic and Volumetric Biomarker Changes With Cognitive Decline in Clinically Normal Adults.
    Neurology. 2023;101:e2533-e2544.
    

    >> Share

    
    November 2023
11. YOON SH, Kim HK, Lee JH, Chun JH, et al
    Association of Sleep Disturbances With Brain Amyloid and Tau Burden, Cortical Atrophy, and Cognitive Dysfunction Across the AD Continuum.
    Neurology. 2023;101:e2162-e2171.
    

    >> Share

    
    October 2023
12. THEIS H, Bischof GN, Bruggemann N, Dargvainiene J, et al
    In Vivo Measurement of Tau Depositions in Anti-IgLON5 Disease Using (18)F-PI-2620 PET.
    Neurology. 2023 Oct 25:10.1212/WNL.0000000000207870.
    

    >> Share

    
    
13. BEAUCHAMP LC, Dore V, Villemagne VL, Xu S, et al
    Utilizing (18)F-AV-133 VMAT2 PET Imaging to Monitor Progressive Nigrostriatal Degeneration in Parkinson Disease.
    Neurology. 2023 Oct 10:10.1212/WNL.0000000000207748.
    

    >> Share

    
    September 2023
14. COOMANS EM, de Koning LA, Rikken RM, Verfaillie SC, et al
    Performance of a [(18)F]Flortaucipir PET Visual Read Method Across the Alzheimer Disease Continuum and in Dementia With Lewy Bodies.
    Neurology. 2023 Sep 25:10.1212/WNL.0000000000207794.
    

    >> Share

    
    
15. CHEVAL M, Rodrigo S, Leroy C, Taussig D, et al
    [(18)F]DPA-714 PET Imaging in the Presurgical Evaluation of Patients With Drug-Resistant Focal Epilepsy.
    Neurology. 2023 Sep 25:10.1212/WNL.0000000000207811.
    

    >> Share

    
    
16. MALPETTI M, Rabinovici GD
    From Clinical Trials to Memory Clinics, tau-PET Visual Reads Can Help Diagnosis and Patient Stratification.
    Neurology. 2023 Sep 25:10.1212/WNL.0000000000207935.
    

    >> Share

    
    August 2023
17. SELVARAJAN JMP, Epari S, Sahu A, Dasgupta A, et al
    Pearls & Oy-sters: Primary Diffuse Leptomeningeal Melanocytosis: A Diagnostic Conundrum.
    Neurology. 2023;101:e576-e580.
    

    >> Share

    
    July 2023
18. DURCAN R, Roberts G, Hamilton CA, Donaghy PC, et al
    Serial Nigrostriatal Dopaminergic Imaging in Mild Cognitive Impairment With Lewy Bodies, Alzheimer Disease, and Age-Matched Controls.
    Neurology. 2023 Jul 31:10.1212/WNL.0000000000207621.
    

    >> Share

    
    
19. ANDRE C, Kuhn E, Rehel S, Ourry V, et al
    Association of Sleep-Disordered Breathing and Medial Temporal Lobe Atrophy in Cognitively Unimpaired Amyloid-Positive Older Adults.
    Neurology. 2023;101:e370-e385.
    

    >> Share

    
    
20. PROKOPIOU PC, Engels-Dominguez N, Schultz AP, Sepulcre J, et al
    Association of Novelty-Related Locus Coeruleus Function With Entorhinal Tau Deposition and Memory Decline in Preclinical Alzheimer Disease.
    Neurology. 2023 Jul 25:10.1212/WNL.0000000000207646.
    

    >> Share

    
    
21. QUINN C, Moulton K, Farwell M, Le W, et al
    Imaging With PET/CT of Diffuse CD8 T Cell Infiltration of Skeletal Muscle in Patients with Inclusion Body Myositis.
    Neurology. 2023 Jul 24:10.1212/WNL.0000000000207596.
    

    >> Share

    
    
22. LICHTER DG, Hershey L
    Proposal to Add FDG-PET as an Outcome Measure for Clinical Trials in Patients With Prodromal Lewy Body Dementia.
    Neurology. 2023 Jul 3:10.1212/WNL.0000000000207498.
    

    >> Share

    
    May 2023
23. DIAZ-GALVAN P, Przybelski SA, Lesnick TG, Schwarz CG, et al
    beta-Amyloid Load on PET Along the Continuum of Dementia With Lewy Bodies.
    Neurology. 2023 May 18:10.1212/WNL.0000000000207393.
    

    >> Share

    
    
24. LUO J, Ma Y, Agboola FJ, Grant E, et al
    Longitudinal Relationships of White Matter Hyperintensities and Alzheimer Disease Biomarkers Across the Adult Lifespan.
    Neurology. 2023 May 18:10.1212/WNL.0000000000207378.
    

    >> Share

    
    
25. CLARKE AJ, Manser D, Fleischer GradDipGC R, Fulham M, et al
    Pearls and Oy-sters: Huntington Disease Presenting as Primary Progressive Aphasia: A Case of Semantics.
    Neurology. 2023 May 18:10.1212/WNL.0000000000207428.
    

    >> Share

    
    
26. DU J, Li A, Shi D, Chen X, et al
    Association of APOE4, Osteoarthritis, beta-Amyloid, and Tau Accumulation in Primary Motor and Somatosensory Regions in Alzheimer Disease.
    Neurology. 2023 May 15:10.1212/WNL.0000000000207369.
    

    >> Share

    
    April 2023
27. LEWIS A, Galetta S
    Editors' Note: Hyperacute Perfusion Imaging Before Pediatric Thrombectomy: Analysis of the Save ChildS Study.
    Neurology. 2023;100:842.
    

    >> Share

    
    
28. SIEGLER JE, Nguyen TN
    Reader Response: Hyperacute Perfusion Imaging Before Pediatric Thrombectomy: Analysis of the Save ChildS Study.
    Neurology. 2023;100:842-843.
    

    >> Share

    
    
29. LEE S
    Author Response: Hyperacute Perfusion Imaging Before Pediatric Thrombectomy: Analysis of the Save ChildS Study.
    Neurology. 2023;100:843.
    

    >> Share

    
    
30. KUHN E, Perrotin A, La Joie R, Touron E, et al
    Association of the Informant-Reported Memory Decline With Cognitive and Brain Deterioration Through the Alzheimer Clinical Continuum.
    Neurology. 2023 Apr 21:10.1212/WNL.0000000000207338.
    

    >> Share

    
    
31. INSEL PS, Kumar A, Hansson O, Mattsson-Carlgren N, et al
    Genetic Moderation of the Association of beta-Amyloid With Cognition and MRI in Alzheimer Disease.
    Neurology. 2023 Apr 21:10.1212/WNL.0000000000207305.
    

    >> Share

    
    
32. TIAN J, Raghavan Pillai SK, Reid RI, Przybelski SA, et al
    White Matter Degeneration Pathways Associated With Tau Deposition in Alzheimer Disease.
    Neurology. 2023 Apr 17:10.1212/WNL.0000000000207250.
    

    >> Share

    
    March 2023
33. KATSANOS AH, Catanese L, Shoamanesh A
    To Use Perfusion Imaging or Not in Patient Selection for Late Time-Window Endovascular Thrombectomy? That Is the Question.
    Neurology. 2023 Mar 29:10.1212/WNL.0000000000207357.
    

    >> Share

    
    February 2023
34. FERREIRA D, Przybelski SA, Lesnick TG, Schwarz CG, et al
    Cross-sectional Associations of beta-Amyloid, Tau, and Cerebrovascular Biomarkers With Neurodegeneration in Probable Dementia With Lewy Bodies.
    Neurology. 2023;100:e846-e859.
    

    >> Share

    
    January 2023
35. OHRFELT A, Benedet AL, Ashton NJ, Kvartsberg H, et al
    Association of CSF GAP-43 With the Rate of Cognitive Decline and Progression to Dementia in Amyloid-Positive Individuals.
    Neurology. 2023;100:e275-e285.
    

    >> Share

    
    December 2022
36. LEE S, Mlynash M, Christensen S, Jiang B, et al
    Hyperacute Perfusion Imaging Before Pediatric Thrombectomy: Analysis of the Save ChildS Study.
    Neurology. 2022 Dec 21:10.1212/WNL.0000000000201687.
    

    >> Share

    
    
37. DLAMINI N, Stence N
    Hyperacute Perfusion Imaging Before Pediatric Thrombectomy: One step closer.
    Neurology. 2022 Dec 21:10.1212/WNL.0000000000206819.
    

    >> Share

    
    October 2022
38. MICHIELS L, Thijs L, Mertens N, Sunaert S, et al
    In Vivo Detection of Neurofibrillary Tangles by 18F-MK-6240 PET/MR in Patients With Ischemic Stroke.
    Neurology. 2022 Oct 27. pii: WNL.0000000000201344.
    

    >> Share

    
    
39. QUISPIALAYA KM, Therriault J, Aliaga A, Zimmermann M, et al
    Discordance and Concordance Between Cerebrospinal and [18F]FDG-PET Biomarkers in Assessing Atypical and Early-Onset AD Dementia Cases.
    Neurology. 2022 Oct 20. pii: WNL.0000000000201198.
    

    >> Share

    
    
40. TAJFIROUZ D, Chen JJ, Bhatti MT
    Clinical Reasoning: An 80-Year-Old Woman With a Homonymous Hemianopsia.
    Neurology. 2022;99:713-717.
    

    >> Share

    
    
41. SARRAJ A, Campbell BCV, Pujara D, Albers GW, et al
    Author Response: Accuracy of CT Perfusion-Based Core Estimation of Follow-up Infarction: Effects of Time Since Last Known Well.
    Neurology. 2022;99:633.
    

    >> Share

    
    
42. GARCIA-TORNEL GARCIA-CAMBA A, Ribo M
    Reader Response: Accuracy of CT Perfusion-Based Core Estimation of Follow-up Infarction: Effects of Time Since Last Known Well.
    Neurology. 2022;99:632-633.
    

    >> Share

    
    
43. CHUNG SJ, Kim YJ, Kim YJ, Lee HS, et al
    Association Between White Matter Networks and the Pattern of Striatal Dopamine Depletion in Patients With Parkinson Disease.
    Neurology. 2022 Oct 4. pii: WNL.0000000000201269.
    

    >> Share

    
    September 2022
44. SHIMOHAMA S, Tezuka T, Keisuke T, Bun S, et al
    Impact of Amyloid and Tau PET on Changes in Diagnosis and Patient Management.
    Neurology. 2022 Sep 29. pii: WNL.0000000000201389.
    

    >> Share

    
    
45. DEMNITZ-KING H, Gonneaud J, Klimecki OM, Chocat A, et al
    Association of Self-reflection With Cognition and Brain Health in Cognitively Unimpaired Older Adults.
    Neurology. 2022;99:e1422-e1431.
    

    >> Share

    
    
46. KARALIJA N, Johansson J, Papenberg G, Wahlin A, et al
    Longitudinal Dopamine D2 Receptor Changes and Cerebrovascular Health in Aging.
    Neurology. 2022;99:e1278-e1289.
    

    >> Share

    
    
47. KAMAGATA K, Andica C, Takabayashi K, Saito Y, et al
    Association of MRI Indices of Glymphatic System With Amyloid Deposition and Cognition in Mild Cognitive Impairment and Alzheimer Disease.
    Neurology. 2022 Sep 19. pii: WNL.0000000000201300.
    

    >> Share

    
    
48. YEN K, Yaworski A, Bussiere M, Ba F, et al
    Pearls & Oy-sters: A Case Report of Holmes Tremor Due to Nigrostriatal Dopamine Disruption That Responded to Dopamine Replacement Therapy.
    Neurology. 2022;99:480-483.
    

    >> Share

    
    August 2022
49. SEIBYL JP, Kuo P
    What Is the Role of Dopamine Transporter Imaging in Parkinson Prevention Clinical Trials?
    Neurology. 2022;99.
    

    >> Share

    
    
50. DUMURGIER J, Sabia S, Zetterberg H, Teunissen CE, et al
    A Pragmatic, Data-Driven Method to Determine Cutoffs for CSF Biomarkers of Alzheimer Disease Based on Validation Against PET Imaging.
    Neurology. 2022;99:e669-e678.
    

    >> Share

    
    
51. AKINCI M, Pena-Gomez C, Operto G, Fuentes-Julian S, et al
    Pre-pandemic Alzheimer Disease Biomarkers and Anxious-Depressive Symptoms During the COVID-19 Confinement in Cognitively Unimpaired Adults.
    Neurology. 2022 Aug 2. pii: WNL.0000000000200948.
    

    >> Share

    
    July 2022
52. KEUSS SE, Coath W, Nicholas JM, Poole T, et al
    Associations of beta-Amyloid and Vascular Burden With Rates of Neurodegeneration in Cognitively Normal Members of the 1946 British Birth Cohort.
    Neurology. 2022;99:e129-e141.
    

    >> Share

    
    June 2022
53. PETERSEN KK, Lipton RB, Grober E, Davatzikos C, et al
    Predicting Amyloid Positivity in Cognitively Unimpaired Older Adults: A Machine Learning Approach Using A4 Data.
    Neurology. 2022;98:e2425-e2435.
    

    >> Share

    
    May 2022
54. DUMURGIER J, Sabia S, Zetterberg H, Teunissen C, et al
    Pragmatic, Data-Driven Method to Determine Cutoffs for CSF Biomarkers of Alzheimer Disease Based on Validation Against PET Imaging.
    Neurology. 2022 May 26. pii: WNL.0000000000200735.
    

    >> Share

    
    
55. ASKEN BM, Tanner JA, VandeVrede L, Mantyh WG, et al
    Plasma P-tau181 and P-tau217 in Patients With Traumatic Encephalopathy Syndrome With and Without Evidence of Alzheimer Disease Pathology.
    Neurology. 2022 May 16. pii: WNL.0000000000200678.
    

    >> Share

    
    April 2022
56. COLLIJ LE, Salvado G, Wottschel V, Mastenbroek SE, et al
    Spatial-Temporal Patterns of beta-Amyloid Accumulation: A Subtype and Stage Inference Model Analysis.
    Neurology. 2022;98:e1692-e1703.
    

    >> Share

    
    
57. SARRAJ A, Campbell BCV, Christensen S, Sitton CW, et al
    Accuracy of CT Perfusion-Based Core Estimation of Follow-Up Infarction: Effects of Time-Since-Last-Known-Well.
    Neurology. 2022 Apr 21. pii: WNL.0000000000200269.
    

    >> Share

    
    
58. SWART G, Balgobind S, Chan C, Fulham M, et al
    Spinal Cord Presentation of Biopsy-Proven PET-Positive Giant Cell Arteritis.
    Neurology. 2022 Apr 15. pii: WNL.0000000000200749.
    

    >> Share

    
    
59. MYERS PS, O'Donnell JL, Jackson JJ, Lessov-Schlaggar CN, et al
    Proteinopathy and Longitudinal Cognitive Decline in Parkinson Disease.
    Neurology. 2022 Apr 13. pii: WNL.0000000000200344.
    

    >> Share

    
    
60. FARRELL ME, Papp KV, Buckley RF, Jacobs HIL, et al
    Association of Emerging beta-Amyloid and Tau Pathology With Early Cognitive Changes in Clinically Normal Older Adults.
    Neurology. 2022;98:e1512-e1524.
    

    >> Share

    
    
61. TIDEMAN P, Stomrud E, Leuzy A, Mattsson-Carlgren N, et al
    Association of beta-Amyloid Accumulation With Executive Function in Adults With Unimpaired Cognition.
    Neurology. 2022;98:e1525-e1533.
    

    >> Share

    
    March 2022
62. JOSEPHS KA, Weigand SD, Whitwell J
    Characterizing Amyloid Positive Individuals With Normal Tau PET Levels After 5 Years: An ADNI Study.
    Neurology. 2022 Mar 21. pii: WNL.0000000000200287.
    

    >> Share

    
    
63. XIE N, Zhou Y
    Clinical Reasoning: Longitudinally Extensive Spinal Cord Lesions in a Middle-aged Man.
    Neurology. 2022;98:419-424.
    

    >> Share

    
    
64. MATSUBARA T, Kameyama M, Tanaka N, Sengoku R, et al
    Autopsy Validation of the Diagnostic Accuracy of (123)I-Metaiodobenzylguanidine Myocardial Scintigraphy for Lewy Body Disease.
    Neurology. 2022 Mar 7. pii: WNL.0000000000200110.
    

    >> Share

    
    February 2022
65. GROBER E, Lipton RB, Sperling RA, Papp KV, et al
    Associations of Stages of Objective Memory Impairment (SOMI) with Amyloid PET and Structural MRI: The A4 Study.
    Neurology. 2022 Feb 23. pii: WNL.0000000000200046.
    

    >> Share

    
    
66. PASCUAL B, Hodics T, Funk Q, Cykowski MD, et al
    Translocator Protein 18 kDa PET Imaging Highlights Asymptomatic Isolated Cerebellar Dysplasia.
    Neurology. 2022 Feb 7. pii: WNL.0000000000200221.
    

    >> Share

    
    December 2021
67. YOO HS, Jeon S, Cavedo E, Ko M, et al
    Association of beta-Amyloid and Basal Forebrain With Cortical Thickness and Cognition in Alzheimer and Lewy Body Disease Spectra.
    Neurology. 2021 Dec 30. pii: WNL.0000000000013277.
    

    >> Share

    
    
68. LI Y, Schindler SE, Bollinger JG, Ovod V, et al
    Validation of Plasma Amyloid-beta 42/40 for Detecting Alzheimer Disease Amyloid Plaques.
    Neurology. 2021 Dec 14. pii: WNL.0000000000013211.
    

    >> Share

    
    October 2021
69. DELVA A, Michiels L, Koole M, Van Laere K, et al
    Synaptic Damage and Its Clinical Correlates in People With Early Huntington Disease: A PET Study.
    Neurology. 2021 Oct 18. pii: WNL.0000000000012969.
    

    >> Share

    
    
70. MCCABE JJ, Camps-Renom P, Giannotti N, McNulty JP, et al
    Carotid Plaque Inflammation Imaged by PET and Prediction of Recurrent Stroke at 5 Years.
    Neurology. 2021 Oct 5. pii: WNL.0000000000012909.
    

    >> Share

    
    September 2021
71. MILA-ALOMA M, Brinkmalm A, Ashton NJ, Kvartsberg H, et al
    CSF Synaptic Biomarkers in the Preclinical Stage of Alzheimer Disease and Their Association With MRI and PET: A Cross-sectional Study.
    Neurology. 2021 Sep 23. pii: WNL.0000000000012853.
    

    >> Share

    
    
72. SCHINDLER S, Li Y, Buckles VD, Gordon BA, et al
    Predicting Symptom Onset in Sporadic Alzheimer Disease With Amyloid PET.
    Neurology. 2021 Sep 9. pii: WNL.0000000000012775.
    

    >> Share

    
    
73. MCCARTER S, Lesnick TG, Lowe V, Mielke MM, et al
    Cerebral Amyloid Angiopathy Pathology and Its Association With Amyloid-beta PET Signal.
    Neurology. 2021 Sep 9. pii: WNL.0000000000012770.
    

    >> Share

    
    August 2021
74. BEUCLER N
    Reader Response: Scan-Negative Cauda Equina Syndrome: A Prospective Cohort Study.
    Neurology. 2021;97:457.
    

    >> Share

    
    
75. HOERITZAUER I, Carson A, Statham P, Demetriades A, et al
    Author Response: Scan-Negative Cauda Equina Syndrome: A Prospective Cohort Study.
    Neurology. 2021;97:456-457.
    

    >> Share

    
    
76. AMELOT A, Planty-Bonjour A, Terrier LM
    Reader Response: Scan-Negative Cauda Equina Syndrome: A Prospective Cohort Study.
    Neurology. 2021;97:455-456.
    

    >> Share

    
    
77. FRISON E, Proust-Lima C, Mangin JF, Habert MO, et al
    Diabetes Mellitus and Cognition: Pathway Analysis in the MEMENTO Cohort.
    Neurology. 2021;97:e836-e848.
    

    >> Share

    
    July 2021
78. 
    [(11)C]PK11195-PET Brain Imaging of the Mitochondrial Translocator Protein in Mitochondrial Disease.
    Neurology. 2021 Jul 27. pii: WNL.0000000000012559.
    

    >> Share

    
    
79. WOLTERS EE, Papma JM, Verfaillie SCJ, Visser D, et al
    [18F]Flortaucipir PET Across Various MAPT Mutations in Presymptomatic and Symptomatic Carriers.
    Neurology. 2021 Jul 1. pii: WNL.0000000000012448.
    

    >> Share

    
    June 2021
80. TODISCO M, Zangaglia R, Minafra B, Pisano P, et al
    Clinical Outcome and Striatal Dopaminergic Function After Shunt Surgery in Patients With Idiopathic Normal Pressure Hydrocephalus.
    Neurology. 2021;96:e2861-e2873.
    

    >> Share

    
    
81. BUCIUC M, Duffy JR, Machulda MM, Graff-Radford J, et al
    Clinical, Imaging, and Pathologic Characteristics of Patients With Right Versus Left Hemisphere-Predominant Logopenic Progressive Aphasia.
    Neurology. 2021 Jun 4. pii: WNL.0000000000012322.
    

    >> Share

    
    May 2021
82. SHIN JH, Lee JY, Kim YK, Yoon EJ, et al
    Parkinson Disease-Related Brain Metabolic Patterns and Neurodegeneration in Isolated REM Sleep Behavior Disorder.
    Neurology. 2021 May 19. pii: WNL.0000000000012228.
    

    >> Share

    
    
83. SARACINO D, Ferrieux S, Nogues-Lassiaille M, Houot M, et al
    Primary Progressive Aphasia Associated With GRN Mutations: New Insights Into the Non-amyloid Logopenic Variant.
    Neurology. 2021 May 12. pii: WNL.0000000000012174.
    

    >> Share

    
    
84. MAYBLYUM DV, Becker JA, Jacobs HIL, Buckley RF, et al
    Comparing PET and MRI Biomarkers Predicting Cognitive Decline in Preclinical Alzheimer Disease.
    Neurology. 2021 May 5. pii: WNL.0000000000012108.
    

    >> Share

    
    April 2021
85. BOERWINKLE AH, Wisch JK, Chen CD, Gordon BA, et al
    Temporal Correlation of CSF and Neuroimaging in the Amyloid-Tau-Neurodegeneration Model of Alzheimer Disease.
    Neurology. 2021 Apr 30. pii: WNL.0000000000012123.
    

    >> Share

    
    
86. RIOU A, Houvenaghel JF, Dondaine T, Drapier S, et al
    Functional Role of the Cerebellum in Parkinson Disease: A PET Study.
    Neurology. 2021 Apr 28. pii: WNL.0000000000012036.
    

    >> Share

    
    
87. NASCIMENTO FA, Cochran RL, Chow DZ, Scott JA, et al
    Teaching NeuroImages: Increasing SPECTations for Ictal SPECT in Epilepsy Surgical Evaluation.
    Neurology. 2021 Apr 26. pii: WNL.0000000000012097.
    

    >> Share

    
    
88. VAN DEN AMEELE J, Hong Y, Manavaki R, Kouli A, et al
    [11C]PK11195-PET Brain Imaging of the Mitochondrial Translocator Protein in Mitochondrial Disease.
    Neurology. 2021 Apr 21. pii: WNL.0000000000012033.
    

    >> Share

    
    
89. ROBERTS G, Durcan Mrcpi R, Donaghy PC, Lawley S, et al
    Accuracy of Cardiac Innervation Scintigraphy for Mild Cognitive Impairment With Lewy Bodies.
    Neurology. 2021 Apr 21. pii: WNL.0000000000012060.
    

    >> Share

    
    
90. SCHOEMAKER D, Charidimou A, Zanon Zotin MC, Raposo N, et al
    Association of Memory Impairment With Concomitant Tau Pathology in Patients With Cerebral Amyloid Angiopathy.
    Neurology. 2021;96:e1975-e1986.
    

    >> Share

    
    March 2021
91. TOPPALA S, Ekblad LL, Tuisku J, Helin S, et al
    Association of Early beta-Amyloid Accumulation and Neuroinflammation Measured With [(11)C]PBR28 in Elderly Individuals Without Dementia.
    Neurology. 2021;96:e1608-e1619.
    

    >> Share

    
    
92. POIRION E, Tonietto M, Lejeune FX, Ricigliano VAG, et al
    Structural and Clinical Correlates of a Periventricular Gradient of Neuroinflammation in Multiple Sclerosis.
    Neurology. 2021 Mar 18. pii: WNL.0000000000011700.
    

    >> Share

    
    
93. BARKHOF BF, Pressman PS
    Time Is of the Essence: Early Detection of Incipient Alzheimer Pathology.
    Neurology. 2021 Mar 2. pii: WNL.0000000000011739.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share